CVRx (CVRX) EBIT Margin (2020 - 2026)

CVRx's (CVRX) quarterly EBIT Margin came in at 82.34% in Q1 2026, up 2648.0% year-on-year from 3.0% in Q1 2025, and down 17.98% quarter-over-quarter from 69.8% in Q4 2025.

CVRx (CVRX) EBIT Margin (2020 - 2026) Analysis & Trends

CVRx's EBIT Margin history runs 7 years deep, the most recent figure standing at 82.34% for Q1 2026.

  • On a quarterly basis, EBIT Margin rose 2648.0% year-over-year to 82.34% in Q1 2026; TTM through Mar 2026 was 84.62%, a 1126.0% increase from a year earlier, with the FY2025 full-year figure at 90.49%, up 2549.0% from the prior year.
  • EBIT Margin retreated to 82.34% in Q1 2026 per CVRX's latest filing, from 69.8% in the prior quarter.
  • Across five years, EBIT Margin topped out at 66.97% in Q4 2024 and bottomed at 243.08% in Q1 2022.
  • The 5-year median for EBIT Margin is 108.82% (2025), against an average of 128.07%.
  • Across the five-year window, EBIT Margin sank 9563 bps in 2022 and jumped 9761 bps in 2025, its largest moves.
  • Year by year, EBIT Margin stood at 159.96% in 2022, then soared by 47 bps to 85.46% in 2023, then rose by 22 bps to 66.97% in 2024, then decreased by 4 bps to 69.8% in 2025, then fell by 18 bps to 82.34% in 2026.
  • Per Business Quant, the three latest CVRX EBIT Margin figures stand at 82.34% (Q1 2026), 69.8% (Q4 2025), and 83.51% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 12.05%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 15.55%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 19.10%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 28.97%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 21.42%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 6.17%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 10.04%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 CVRx 128.88 Mn 56.58 Mn 12.88 Mn -82.34%

Historic Data

Download Data
DateValue
Mar 31, 2026 -82.34%
Dec 31, 2025 -69.80%
Sep 30, 2025 -83.51%
Jun 30, 2025 -105.79%
Mar 31, 2025 -108.82%
Dec 31, 2024 -66.97%
Sep 30, 2024 -97.29%
Jun 30, 2024 -118.35%
Mar 31, 2024 -206.43%
Dec 31, 2023 -85.46%
Sep 30, 2023 -90.65%
Jun 30, 2023 -123.71%
Mar 31, 2023 -152.43%
Dec 31, 2022 -159.96%
Sep 30, 2022 -163.69%
Jun 30, 2022 -218.92%
Mar 31, 2022 -243.08%
Dec 31, 2021 -240.24%
Sep 30, 2021 -214.76%
Jun 30, 2021 -181.62%